Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15529553http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

The purpose of our study was to evaluate the significance of polymorphisms in HLA class II genes in coronary artery ectasia (CAE) patients.

Methods and results

Twenty-six patients with CAE without associated cardiac defects were enrolled in the study. CAE was defined as luminal dilation of 1.5-to 2.0-fold of normal limits. Ninety-five healthy subjects who were donors for different organ transplantations, were chosen as control group. Physical examination, electrocardiography and chest X-ray were completely normal in these cases. Both the patients and the control group were screened and compared for their HLA class II genotypes. HLA-DR B1*13, DR16, DQ2 and DQ5 genotypes were significantly more frequent in the patient group. When the known risk factors of coronary heart disease were compared in the patients carrying these genotypes with the non-carrying group, no significant differences were encountered.

Conclusions

HLA-DR B1*13, DR16, DQ2 and DQ5 may be associated with the pathogenesis and increase the risk of CAE."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.org/dc/terms/identifier"doi:10.2143/ac.59.5.2005222"xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Duran S."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Imirzalioglu N."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Yazici M."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Akdemir R."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Albayrak S."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Erbilen E."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Gunduz H."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Orkunoglu F."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Ozhan H."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/author"Uyan C."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/date"2004"xsd:gYear
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/name"Acta Cardiol"xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/pages"499-502"xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/title"HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia."xsd:string
http://purl.uniprot.org/citations/15529553http://purl.uniprot.org/core/volume"59"xsd:string
http://purl.uniprot.org/citations/15529553http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15529553
http://purl.uniprot.org/citations/15529553http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/15529553
http://purl.uniprot.org/uniprot/#_A0A0A7C3H3-mappedCitation-15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15529553
http://purl.uniprot.org/uniprot/#_A0A0A7C3I1-mappedCitation-15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15529553
http://purl.uniprot.org/uniprot/#_A0A0A7C3I5-mappedCitation-15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15529553
http://purl.uniprot.org/uniprot/#_A0A0E3DC97-mappedCitation-15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15529553
http://purl.uniprot.org/uniprot/#_A0A0E3DC99-mappedCitation-15529553http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15529553
▶